###begin article-title 0
Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
To evaluate genes involved in homocysteine metabolism as secondary risk factors for pseudoexfoliation syndrome (PXFS) and the associated glaucoma (PXFG).
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 348 351 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTR</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTRR</italic>
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFD1</italic>
###xml 475 478 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 649 654 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 736 741 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
One hundred eighty-six unrelated patients with PXFS, including 140 patients with PXFG and 127 unrelated control subjects were recruited from the Massachusetts Eye and Ear Infirmary. All the patients and controls were Caucasian of European ancestry. Seventeen tag SNPs from 5 genes (methylenetetrahydrofolate reductase [MTHFR], methionine synthase [MTR], methionine synthase reductase [MTRR], methylenetetrahydrofolate dehydrogenase [MTHFD1], and cystathionine beta-synthase [CBS]) were genotyped. Single-SNP association was analyzed using Fisher's exact test (unconditional) or logistic regression after conditioning on the effects of age and three LOXL1 SNPs (, , and ). Interaction analysis was performed between the homocysteine and LOXL1 SNPs using logistic regression. Haplotype analysis and the set-based test were used to test for association of individual genes. Multiple comparisons were corrected using the Bonferroni method.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFD1</italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
One SNP () in MTHFD1 showed a nominally significant association with PXFG (p=0.015, OR=2.23). None of the seventeen SNPs tested were significantly associated with PXFS or PXFG after correcting for multiple comparisons (Bonferroni corrected p>0.25). After controlling for the effects of age and three associated LOXL1 SNPs, none of the seventeen tested SNPs were associated with PXFS (p>0.12). No significant interaction effects on PXFS were identified between the homocysteine and LOXL1 SNPs (p>0.06). Haplotype analysis and the set-based test did not find significant association of individual genes with PXFS (p>0.23 and 0.20, respectively).
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
Five genes that are critical components of the homocysteine metabolism pathway were evaluated as secondary factors for PXFS and PXFG. Our results suggest that these genes are not significant risk factors for the development of these conditions.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Pseudoexfoliation syndrome (PXFS) is a common condition characterized by the deposition of microfibrillar material throughout the eye. The composition of the PXFS-related material, although not completely defined, appears to be a complex glycoprotein structure containing elements of basement membranes and the elastic fiber system [1]. The biologic processes that cause this material to accumulate in ocular structures are not known. In eyes with PXFS, fibrillar material is found throughout the anterior segment and is typically evident on the lens capsule and in the angle where it may impede the flow of aqueous humor through the trabecular outflow pathways [2]. Over 50% of individuals with PXFS develop high-pressure glaucoma (PXFG) which may be associated with rapidly progressive optic nerve degeneration [3].
###end p 11
###begin p 12
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 875 880 875 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
Pseudoexfoliation syndrome and the associated glaucoma appear to be genetically complex. Twin studies and reports of familial aggregation demonstrated significant heritability but not a clearly defined inheritance pattern, suggesting complex or multifactorial inheritance [4-6]. A genome-wide scan using a large Finnish family indicated potential linkage to multiple chromosome regions including 18q, 2q, 17q, and 19q [7]. Recently, a genome-wide association study identified significant association of three SNPs (, , and ) in the lysyl oxidase-like 1 (LOXL1) gene with PXFS and PXFG in patients from Iceland and Sweden [8]. This association has been replicated in our study of a USA clinic-based population with broad ethnic diversity [9] and in other studies using ethnic populations of Caucasian [10-16], Indian [17], and Japanese [18-22]. These results demonstrate that LOXL1 is a major gene associated with PXFS and PXFG.
###end p 12
###begin p 13
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 313 321 <span type="species:ncbi:9606">patients</span>
Two of the highly associated LOXL1 SNPs are missense changes in exon 1 (, G153D and , R141L), however, it is not yet known if these variants are biologically causative or are in linkage disequilibrium with other gene variants that are biologically active. The G153D risk allele (G) frequency is very high in PXFG patients in most of the populations studied (92%-99%), but is also prevalent in control samples, with a frequency of over 65% in many populations [8-22]. In addition, in the Australian population the frequency of the  risk allele is much higher than the disease prevalence, indicating a reduction in penetrance compared to the USA and European populations [14]. Collectively, these results suggest that additional genetic and/or environmental factors that are potentially additive and/or protective could influence the development of this complex disorder [23].
###end p 13
###begin p 14
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
Previous reports have indicated that homocysteine is moderately elevated in aqueous humor, tear fluid, and serum plasma of patients with PXFS and PXFG [24-26]. It has been proposed that mild elevations of homocysteine may contribute to the increased vascular risk that has been observed in patients with PXFS, which includes aneurysms of the abdominal aorta [27]. It is well recognized that hyperhomocysteinemia is associated with vascular abnormalities [28], and the modest elevations reported in PXFS patients could initiate vascular damage that could be further compromised by abnormal LOXL1 activity. Variants in genes that regulate the homocysteine pathways could be responsible for the observed elevations of homocysteine and these may be additive genetic factors that influence the development of the syndrome. The purpose of this study was to evaluate 5 genes encoding enzymes that regulate homocysteine metabolism as secondary factors that could contribute to PXFS and PXFG.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and control subjects
###end title 16
###begin p 17
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 152 160 <span type="species:ncbi:9606">Patients</span>
###xml 285 293 <span type="species:ncbi:9606">Patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
###xml 1134 1142 <span type="species:ncbi:9606">patients</span>
###xml 1370 1382 <span type="species:ncbi:9606">participants</span>
###xml 1431 1439 <span type="species:ncbi:9606">patients</span>
###xml 1740 1748 <span type="species:ncbi:9606">patients</span>
One hundred eighty-six patients with PXFS were recruited from the Glaucoma Consultation Service at the Massachusetts Eye and Ear Infirmary, Boston, MA. Patients with PXFS were identified by the presence of the characteristic fibrillar material on the lens capsule or pupillary margin. Patients with iris transillumination defects without the presence of the fibrillar material were not identified as pseudoexfoliation patients, or controls. Of the 186 patients with PXFS, 140 had glaucoma (PXFG) and 46 did not (PXFNG). Glaucoma was defined as: intraocular pressure >22 mmHg in both eyes on two occasions or intraocular pressure >19 mmHg in both eyes on treatment with two or more glaucoma medications; evidence of optic nerve damage in both eyes; and visual field defects consistent with optic nerve damage and characteristic for glaucoma in at least one eye. One hundred twenty-seven control subjects were recruited from the Comprehensive Ophthalmology Service at the Massachusetts Eye and Ear Infirmary, Boston, MA. Control subjects had no evidence of pseudoexfoliation or glaucoma after clinical exam. The average age of the PXFS patients was 75. Because of the age-dependence of the pseudoexfoliation syndrome, only controls older than age 60 were used for this analysis with an average age of 72. This study population (cases and controls) included only Caucasian participants of European ancestry. Fifty-nine percent of the patients were female with 41% male, while 51% of the controls were female and 49% were male. This study adhered to the tenets of the Declaration of Helsinki and has been reviewed and approved by the Institutional Review Board of the Massachusetts Eye and Ear Infirmary. Informed consent was obtained from all patients and controls.
###end p 17
###begin title 18
Gene polymorphisms and genotyping
###end title 18
###begin p 19
###xml 110 118 110 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTR</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTRR</italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFD1</italic>
###xml 301 304 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 433 435 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 659 660 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 731 738 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1196 1199 1193 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
Five genes that encode proteins that are involved in homocysteine metabolism were investigated in this study (Figure 1). These genes are MTHFR (methylenetetrahydrofolate reductase), MTR (methionine synthase), MTRR (methionine synthase reductase), MTHFD1 (methylenetetrahydrofolate dehydrogenase), and CBS (cystathionine beta-synthase). Tag SNPs corresponding to linkage disequilibrium (LD) blocks were selected using  (version 4.1) [29] according to the  data (release 23a) from the CEU population. The minimum minor allele frequency for checking markers was set to 0.01. Three or 4 tag SNPs were selected for each gene to capture the majority of alleles at r2 greater than 0.8 across the whole gene including the 5'UTR and 3'UTR (Table 1). Each LD block was captured by 1 or 2 SNPs although not all alleles in each gene were captured. Genotyping was performed either by TaqMan assays (Applied Biosystems [ABI], Foster City, CA) or by direct sequencing. For the TaqMan assays, oligonucleotide primers were ordered from ABI (assay by demand) and performed according to the manufacturer's instructions. For direct sequencing, products from PCR amplification were purified and sequenced using BigDye(R) chemistries (ABI) and an automated genetic analyzer (model 3100; ABI). Sequence data was analyzed using  suite (version 8).
###end p 19
###begin p 20
###xml 252 255 252 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B12</bold>
###xml 270 275 270 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHMT,</bold>
###xml 316 319 316 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</bold>
###xml 350 353 350 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHF</bold>
###xml 370 374 370 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHFR</bold>
###xml 401 405 401 405 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dTMP</bold>
###xml 432 436 432 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dUMP</bold>
###xml 461 464 461 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FAD</bold>
###xml 495 498 495 498 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLY</bold>
###xml 509 515 509 515 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFD1</bold>
###xml 598 603 598 603 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</bold>
###xml 642 645 642 645 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTR</bold>
###xml 704 708 704 708 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTRR</bold>
###xml 777 779 777 779 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MT</bold>
###xml 801 804 801 804 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SAH</bold>
###xml 840 843 840 843 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SER</bold>
###xml 853 856 853 856 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THF</bold>
###xml 876 878 876 878 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TS</bold>
###xml 902 911 902 911 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5-CH3-THF</bold>
###xml 940 952 940 952 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5,10-CH2=THF</bold>
###xml 982 994 982 994 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5,10=CH2-THF</bold>
###xml 1023 1033 1023 1033 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10-CHO-THF</bold>
Homocysteine metabolic pathways. Products of the enzymatic pathways are shown in rectangles, co-factors are shown in circles, and enzymes are in text. The genes coding for the enzymes included in this study are shown as underlined text. Abbreviations: B12, vitamin B12; BHMT, betaine-homocysteine methyltransferase; CBS, cystathionine beta synthase; DHF, dihydrofolate; DHFR, dihydrofolate reductase; dTMP, thymidine monophosphate; dUMP, uridine monophosphate; FAD, flavin adenine dinucleotide; GLY, glycine; MTHFD1, trifunctional methylenetetrahydrofolate dehydrogenase, cyclohydrolase, synthase; MTHFR, methylenetetrahydrofolate reductase; MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase; MTRR, 5-methyltetrahydrofolate-homocysteine methyltransferase reductase; MT, methyl transferase; SAH, S-adenosylhomocysteine hydrolase; SER, serine; THF, tetrahydrofolate; TS, thymidylate synthase; 5-CH3-THF, 5-methyl tetrahydrofolate; 5,10-CH2=THF, methylene tetrahydrofolate; 5,10=CH2-THF, methenyl tetrahydrofolate; 10-CHO-THF, 10-formyl tetrahydrofolate.
###end p 20
###begin title 21
Characteristics and genotype counts of the 17 SNPs in 5 homocysteine genes.
###end title 21
###begin p 22
The asterisk indicates that "A" represents the minor allele and "B" represents the common allele.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 114 115 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 165 166 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 617 622 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 826 831 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 1110 1111 1106 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1391 1393 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
Statistical analyses were performed using  (version 1.04) [30]. Hardy-Weinberg equilibrium was assessed by the chi2 test. Linkage disequilibrium was measured using r2. Initial single-SNP association analysis was performed using the Fisher's exact test. Multivariable analysis of individual SNPs was performed using logistic regression models. The additive effects model was applied to analysis of allele dosage in which the genotypes AA, AB, BB were coded as 0, 1, 2, respectively, where A represents the minor allele and B represents the common allele. After controlling for the effects of age and three significant LOXL1 SNPs (, , and ), individual SNPs in the homocysteine genes were analyzed for association with PXFS using logistic regression. Interaction analysis of pair-wise SNPs between the homocysteine SNPs and the LOXL1 SNPs was performed by including an interaction term in the logistic regression models. Haplotype analysis and the set-based test were used to test for association of individual genes. Haplotype frequencies were estimated using the standard E-M algorithm and tested using the chi2 test. The omnibus p-values for haplotype analysis were obtained from the omnibus test. The set-based test selects the best set of SNPs whose mean of these single SNP statistics is significant after permutation, which is particularly suited to large-scale candidate gene studies [31]. The empirical p values of the set-based test were obtained by a permutation of 10,000 times of phenotype labels. Multiple comparisons were corrected using the Bonferroni method.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
Single-SNP association analysis
###end title 26
###begin p 27
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFD1</italic>
###xml 626 633 626 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
Seventeen SNPs in five genes were analyzed for association with PXFS, PXFG, and PXFNG (Table 1). All of these SNPs followed Hardy-Weinberg equilibrium in both cases and controls (p>0.05). The selected SNPs were not in strong LD (r2<0.26), which is consistent with the HapMap data from the CEU population. Only one SNP,  in MTHFD1, showed a marginally significant association with PXFS (p=0.015; OR=2.07, 95%CI: 1.16, 3.71) and PXFG (p=0.015; OR=2.23, 95%CI: 1.19, 4.16). However, none of these SNPs were significantly associated with PXFS, PXFG or PXFNG after correcting for multiple comparisons (Bonferroni corrected p>0.25; Table 2).
###end p 27
###begin title 28
Single-SNP association of homocysteine genes with PXFS, PXFG and PXFNG.
###end title 28
###begin p 29
The asterisk indicates that p values were obtained from Fisher's exact test when compared to controls. The Bonferroni corrected significance level was 0.003 (0.05/17).
###end p 29
###begin p 30
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 214 221 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
After controlling for the effects of age and the three significant LOXL1 SNPs (, , and ), logistic regression analysis also showed that none of the SNPs in the homocysteine genes were associated with PXFS (p>0.12; Table 3). No significant interaction effects on PXFS were found between the homocysteine SNPs and the LOXL1 SNPs (p>0.06; data not shown).
###end p 30
###begin title 31
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Single-SNP association of homocysteine genes with PXFS after controlling for the effects of age and 3 LOXL1 SNPs.
###end title 31
###begin p 32
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
The asterisk indicates that p values and odds ratios (OR) with 95% confidence intervals (CI) were obtained from logistic regression analysis of single-SNP association of homocysteine genes with PXFS after controlling for the effects of age and the 3 LOXL1 SNPs (, , and ).
###end p 32
###begin title 33
Gene-based association analysis
###end title 33
###begin p 34
###xml 135 142 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 297 304 297 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
Haplotype association analysis of all the tag SNPs in each gene revealed no association of individual genes with PXFS (omnibus p>0.23; Table 4). Set-based association tests also did not identify significant association of individual genes with PXFS (empirical p>0.04, Bonferroni corrected p>0.20; Table 4).
###end p 34
###begin title 35
Gene-based association of homocysteine genes with PXFS.
###end title 35
###begin p 36
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
The asterisk indicates that the p values were obtained from the omnibus haplotype test using PLINK (version 1.04) [30] and the the sharp (hash mark) indicates that the p values were obtained from the set-based test by a permutation of 10,000 times using PLINK (version 1.04) [30]. The Bonferroni corrected significance level was 0.01 (0.05/5).
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
Recent studies suggest that LOXL1 is a major gene associated with PXFS/PXFG, contributing to the majority of cases in most populations [8-22]. However, the high prevalence of the  risk allele in control populations, and the apparent variable penetrance of the condition in some populations suggest that additional genetic factors and/or environmental exposures could be involved in the development of this complex disease. As moderate hyperhomocysteinemia has been repeatedly described in PXFS and PXFG patients [24-26], we evaluated the genes that code for proteins involved in homocysteine metabolism as candidates for secondary factors contributing to this disease.
###end p 38
###begin p 39
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 1260 1265 1260 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Multiple reports have indicated that patients with PXFS have mild elevations of homocysteine in serum plasma, as well as aqueous humor and tear fluid [24-26]. As the association of hyperhomocysteinemia with vascular disease has been well documented [28], and ocular and systemic blood vessels in PXFS can be abnormal [32], we hypothesized that elevated homocysteine caused by variant forms of genes coding for key enzymes involved in homocysteine metabolism could contribute to the PXFS. Defects in LOXL1 can also compromise the elastic structure of blood vessels [33], and that the combined effects of elevated serum homocysteine and LOXL1 deficiency could synergistically contribute to vascular compromise. Abnormalities of ocular vasculature, especially blood vessels in the iris could be related to the deposition of the microfibrillar material that is characteristic of the disease process. Previous studies have failed to show an association between homocysteine metabolism genes and PXFS [34-39], however these studies have evaluated only the well studied common C677T polymorphism () in MTHFR, a central regulator of homocysteine levels. In this study we took a broader approach and evaluated 5 genes involved in homocysteine metabolism, including the MTHFR gene. We did not find any significant association between any of the homocysteine genes and PXFS and/or PXFG in this present study.
###end p 39
###begin p 40
###xml 97 100 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 215 217 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 218 220 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 318 320 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 424 427 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 508 509 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
Cystathionine beta-synthase catalyzes the transsulfuration of homocysteine to cystathionine. The CBS c.844_845ins68 mutation has been associated with increased CBS enzyme activity and decreased homocysteine levels [40,41], and has been hypothesized to have a protective effect against vascular thromboembolic disease [42]. We initially sequenced a sample of 100 patients with PXFS and 100 controls and observed that another CBS variant,  (I278T), was in complete linkage disequilibrium with c.844_845ins68 (r2=1.0). We therefore considered  as a surrogate for c.844_845ins68 and only genotyped  in our subsequent samples using TaqMan assays. In our population, we did not find any association of  with PXFS or PXFG, and so did the c.844_845ins68 mutation.
###end p 40
###begin p 41
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFD1</italic>
###xml 366 373 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 487 494 487 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1233 1240 1233 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1384 1389 1384 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 1400 1407 1400 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
As age and LOXL1 variants are two known major risk factors for PXFS and PXFG, we analyzed the association between SNPs in homocysteine metabolism genes and PXFS and PXFG using logistic regression after controlling for the effects of age and the LOXL1 variants. The MTHFD1 SNP  was marginally associated with PXFG before correction for multiple comparisons (p=0.015; Table 2). However, this association disappeared after controlling for the effects of age and the LOXL1 variants (p=0.21; Table 3). To increase the statistical power to identify a possible association, we further analyzed our data using haplotype analysis and the set-based test, both of which are gene-based tests where all SNPs in a gene are analyzed together. The set-based test is particularly suited to large-scale candidate gene studies [31]. This method selects the best set of SNPs whose mean statistic is significant, leading to the inference that the entire set of SNPs might be interacting in some way to increase disease risk, or else that they are all contributing independently to disease risk. In the present study, both haplotype analysis and the set-based test did not find any significant association between the homocysteine genes and PXFS or PXFG (Table 4), in agreement with the logistic regression analysis of single SNPs in the homocysteine genes after controlling for the effects of age and the LOXL1 variants (Table 3).
###end p 41
###begin p 42
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
We estimated that the present study had 86% of power to detect a moderate genetic effect (genotypic relative risk of 2.0 for Aa and 4.0 for AA, given an additive risk model) [43]. However, this study had only 40% of the power needed to detect a mild genetic effect (genotypic relative risk of 1.5 for Aa and 2.25 for AA, given an additive risk model). In addition, since we used tag SNPs to capture the majority of the variants in each gene, it is possible that we might have missed other variants in these genes associated with the disease. Further large-scale studies and resequencing of the whole genes are warranted to confirm our findings.
###end p 42
###begin p 43
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
Dietary factors that are important regulators of homocysteine metabolism have also been shown to be abnormal in PXFS and PXFG patients including low levels of B6, B12, and folate [44]. It is possible that diets that are low in these vitamins may contribute to these conditons by causing and elevation of homocysteine levels with subsequent interaction with the vascular insult caused by defective LOXL1. Although further documentation is necessary before disease risks can be determined, individuals who are carriers of the LOXL1 at risk genotypes should be encouraged to maintain adequate levels of B6, B12, and folate in their diet.
###end p 43
###begin p 44
In summary, five genes that code for critical components of the homocysteine metabolism pathway were evaluated as secondary factors for PXFS/PXFG in the present study. Our results suggest that variants in these genes are not major risk factors for the development of these conditions. Other important regulators of homocysteine metabolism, such as dietary intake of B6, B12, and folate may be contributing secondary environmental factors. Further studies searching for secondary genetic and environmental factors that contribute to PXFS and PXFG are required to gain a better understanding of the complex etiology of this important ocular disease.
###end p 44
###begin title 45
Acknowledgments
###end title 45
###begin p 46
This work was supported in part by NIH Grants EY015882 and P30EY014104.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
Why is glaucoma associated with exfoliation syndrome?
###end article-title 48
###begin article-title 49
Ocular and systemic pseudoexfoliation syndrome.
###end article-title 49
###begin article-title 50
The risk of glaucoma in pseudoexfoliation syndrome.
###end article-title 50
###begin article-title 51
Family history of glaucoma in the primary and secondary open-angle glaucomas.
###end article-title 51
###begin article-title 52
Familial occurrence of pseudoexfoliation in Canada.
###end article-title 52
###begin article-title 53
Pseudoexfoliation syndrome in Icelandic families.
###end article-title 53
###begin article-title 54
Genome-wide scan of exfoliation syndrome.
###end article-title 54
###begin article-title 55
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
###end article-title 55
###begin article-title 56
DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity.
###end article-title 56
###begin article-title 57
###xml 60 68 <span type="species:ncbi:9606">patients</span>
LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.
###end article-title 57
###begin article-title 58
Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.
###end article-title 58
###begin article-title 59
Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort.
###end article-title 59
###begin article-title 60
Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.
###end article-title 60
###begin article-title 61
###xml 138 144 <span type="species:ncbi:9606">people</span>
Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.
###end article-title 61
###begin article-title 62
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
###end article-title 62
###begin article-title 63
Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.
###end article-title 63
###begin article-title 64
Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India.
###end article-title 64
###begin article-title 65
Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population.
###end article-title 65
###begin article-title 66
Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese.
###end article-title 66
###begin article-title 67
LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population.
###end article-title 67
###begin article-title 68
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome.
###end article-title 68
###begin article-title 69
Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese.
###end article-title 69
###begin article-title 70
Association between LOXL1 and pseudoexfoliation.
###end article-title 70
###begin article-title 71
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma.
###end article-title 71
###begin article-title 72
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma.
###end article-title 72
###begin article-title 73
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma.
###end article-title 73
###begin article-title 74
Pseudoexfoliation syndrome and aneurysms of the abdominal aorta.
###end article-title 74
###begin article-title 75
Homocysteine and cardiovascular disease: a review of the evidence.
###end article-title 75
###begin article-title 76
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 76
###begin article-title 77
PLINK: a tool set for whole-genome association and population-based linkage analyses.
###end article-title 77
###begin article-title 78
Set association analysis of SNP case-control and microarray data.
###end article-title 78
###begin article-title 79
The spectrum of iris angiography abnormalities in pseudoexfoliation syndrome.
###end article-title 79
###begin article-title 80
Down-regulation of lysyl oxydase-like in aging and venous insufficiency.
###end article-title 80
###begin article-title 81
C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma.
###end article-title 81
###begin article-title 82
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation.
###end article-title 82
###begin article-title 83
Methylenetetrahydrofolatereductase (MTHFR) 677C>T polymorphism and open angle glaucoma.
###end article-title 83
###begin article-title 84
###xml 170 178 <span type="species:ncbi:9606">patients</span>
The C677T variant in the methylenetetrahydrofolate reductase gene is not associated with disease in cohorts of pseudoexfoliation glaucoma and primary open-angle glaucoma patients from Iowa.
###end article-title 84
###begin article-title 85
Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma.
###end article-title 85
###begin article-title 86
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma.
###end article-title 86
###begin article-title 87
Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.
###end article-title 87
###begin article-title 88
Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism.
###end article-title 88
###begin article-title 89
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases.
###end article-title 89
###begin article-title 90
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.
###end article-title 90
###begin article-title 91
Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma.
###end article-title 91

